RxDoctor Payments Data

Cindy Lamerson, MD

Dermatology · Reno, NVNPI 1699763201

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.9% of the total across 441 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations.

$8,525in general payments, 2019–2025

Across 441 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$800
  • Incyte Corporation$700
  • Johnson & Johnson$617
  • Sun Pharmaceutical Industries Inc.$528
  • Regeneron Healthcare Solutions, Inc.$460
  • plus $4K from 25 others

What the payments were for

  • Food & beverage$8,09395%
  • Education$4325%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,525 in reported general payments places this provider in the 65th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada

Medicare billing

Part B allowed, 2024
$756,913
Medicare patients
1,256
Services billed
6,736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab31$137,649
Tacrolimus16$3,791
Ketoconazole108$2,250
Fluocinolone Acetonide23$1,216
Clobetasol Propionate30$1,156
ValacyclovirValacyclovir Hcl36$1,098
Mupirocin104$978
Doxycycline Hyclate53$928
Fluocinonide15$738
Imiquimod25$622
Hydroxyzine Hcl53$565
Metronidazole13$533
Triamcinolone Acetonide67$532
Cephalexin34$240
Doxepin Hcl13$218

Paid to pharmacies, not to this prescriber.

Other dermatology in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →